SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: PharmaPoint: Microvascular Complications of Diabetes - UK Drug Forecast and Market Analysis to 2022

[February 25, 2014]

Research and Markets: PharmaPoint: Microvascular Complications of Diabetes - UK Drug Forecast and Market Analysis to 2022

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/xcw8c5/pharmapoint) has announced the addition of the "PharmaPoint: Microvascular Complications of Diabetes - UK Drug Forecast and Market Analysis to 2022" report to their offering.

The entire market for microvascular complications of diabetes (MCD) - diabetic nephropathy, retinopathy, and neuropathy - is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline.

The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the oter hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors.


The currently marketed product with the highest growth rate over the forecast period will be Regeneron/Bayer's Eylea. Despite the drug still being in the pipeline for DME, it is being used off-label already. Its usage will drastically increase upon its approval for the DME indication in 2014.

Scope

- Overview of MCD including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.

- Detailed information on the key drugs in the UK including product description, safety and efficacy profiles as well as a SWOT analysis.

- Sales forecast for the top drugs in the UK from 2012-2022.

- Analysis of the impact of key events as well the drivers and restraints affecting the UK MCD market.

Key Topics Covered:

List of Tables

List of Figures

Introduction

Disease Overview

Disease Management

Competitive Assessment

Opportunity and Unmet Need

Pipeline Assessment

Market Outlook

Appendix

For more information visit http://www.researchandmarkets.com/research/xcw8c5/pharmapoint

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.